Henry Masur earned his undergraduate degree from Dartmouth College and his medical degree from Cornell University Medical College. He completed his internship and residency in internal medicine at New York Hospital and Johns Hopkins Hospital. Following a fellowship at Cornell in the Division of Infectious Diseases and Internal Medicine, he served as an Instructor and Assistant Professor of Medicine in the Infectious Diseases Division at Cornell from 1978 to 1982.
Dr. Masur was recruited to NIH to jointly found a new department of critical care medicine, and an HIV/AIDS program with NIAID. He became Chief of the Critical Care Medicine Department in 1989. During the past 20 years the department has attained national and international acclaim for its leadership in areas of sepsis, emerging infections, HIV/AIDS, lung biology, and sickle cell disease. The department has developed a highly competitive, highly sought training program in critical care medicine which permits candidates to train in pulmonary medicine, infectious diseases, or cardiology as a second subspecialty. The department also has expanded its clinical services and serves as a pivotal component of the NIH Clinical Center which cares for patients with complex medical disorders.
Dr. Masur is well known for his expertise in HIV-related opportunistic infections. His department has published many pivotal studies related in particular to pneumocystis pneumonia. He is the co-editor of the NIH-CDC-IDSA Guidelines for Management of Opportunistic Infections in Adults and Adolescents with HIV Infections, Co-Editor of the textbook AIDS Therapy, and is Past President, Infectious Diseases Society of America. He is also well known in the field of critical care related to infectious diseases, and is the co-chair of IDSA-SCCM Guidelines on Prevention of Intravenous Catheter infections and Evaluation of Fever in the ICU.
Dr. Masur leads the District of Columbia Partnership for AIDS Progress, a unique collaboration between NIH and the DC government which aims to create an urban model for decreasing the impact of HIV/AIDS on underserved populations. The program is focusing on HCV-HIV co-infection, mental health issues, and improving access and adherence to appropriate therapies. He is also active in the NIAID Project Phidisa which works in South Africa with the National Defense Force to study HIV related therapies.
Dr. Masur is Clinical Professor of Medicine at George Washington University and holds appointments at the University of Maryland and the Washington Hospital Center as well.
Selected Honors and Awards
Infectious Diseases Society of America, 2002-2008; (Council 2001-2004, Vice President 2004-2005, President Elect 2005-2006, President 2006-2007, Past President 2007-2008); Feder lectureship, Weill Cornell Medical College, 2008; Zucker Family Lectureship, Weill College of Medicine, Cornell University; 2003; Astute Clinician Lecture, National Institutes of Health, 2002; Kirby Lectureship, University of Washington, 2002; Taubin Memorial Lectureship, Children's National Medical Center, 2002; International Association of Physicians in AIDS Care Hero Award (41 named internationally), 2000; John Phillips Award, American College of Physicians, 2010.
American Society for Clinical Investigation
Association of American Physicians
Morris A, Masur H, Huang L. Current issues in critical care of the human immunodeficiency virus-infected patient. Crit Care Med. 2006 Jan;34(1):42-9.
O'Grady NP, Barie PS, Bartlett JG, Bleck T, Carroll K, Kalil AC, Linden P, Maki DG, Nierman D, Pasculle W, Masur H; American College of Critical Care Medicine; Infectious Diseases Society of America. Guidelines for evaluation of new fever in critically ill adult patients: 2008 Crit Care Med. 2008 Apr;36(4):1330-49.
Masur H, Kaplan JE. New guidelines for the management of HIV-related opportunistic infections. JAMA. 2009 Jun 10;301(22):2378-80.
Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H; Centers for Disease Control and Prevention (CDC); National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009 Apr 10;58(RR-4):1-207.
Kovacs JA, Masur H. Evolving health effects of Pneumocystis: one hundred years of progress in diagnosis and treatment. JAMA. 2009 Jun 24;301(24):2578-85.
Davis JL, Huang L, Kovacs JA, Masur H, Murray P, Havlir DV, Worodria WO, Charlebois ED, Srikantiah P, Cattamanchi A, Huber C, Shea YR, Chow Y, Fischer SH. Polymerase chain reaction of secA1 on sputum or oral wash samples for the diagnosis of pulmonary tuberculosis. Clin Infect Dis. 2009 Mar 15;48(6):725-32.
Greenberg AE, Hader SL, Masur H, Young AT, Skillicorn J, Dieffenbach CW. Fighting HIV/AIDS in Washington, D.C. Health Aff (Millwood). 2009 Nov-Dec;28(6):1677-87.
Hassim S, Shaw PA, Sangweni P, Malan L, Ntshani E, Mathibedi MJ, Stubbs N, Metcalf JA, Eckes R, Masur H, Komati S. Detection of a substantial rate of multidrug-resistant tuberculosis in an HIV-infected population in South Africa by active monitoring of sputum samples. Clin Infect Dis. 2010 Apr 1;50(7):1053-9.
Suffredini AF, Masur H, Lynch JP 3rd. Update in pulmonary and critical care medicine. Ann Intern Med. 2010 May 4;152(9):601-8.
Komati S, Shaw PA, Stubbs N, Mathibedi MJ, Malan L, Sangweni P, Metcalf JA, Masur H, Hassim S. Tuberculosis risk factors and mortality for HIV-infected persons receiving antiretroviral therapy in South Africa. AIDS. 2010 Jul 31;24(12):1849-55.
O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, Raad II, Randolph AG, Rupp ME, Saint S; Healthcare Infection Control Practices Advisory Committee (HICPAC). Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011 May;52(9):e162-93. Epub 2011 Apr 1.
Huang L, Cattamanchi A, Davis JL, den Boon S, Kovacs J, Meshnick S, Miller RF, Walzer PD, Worodria W, Masur H; International HIV-associated Opportunistic Pneumonias (IHOP) Study; Lung HIV Study. HIV-associated Pneumocystis pneumonia. Proc Am Thorac Soc. 2011 Jun;8(3):294-300. Review.
Morris AM, Masur H. A serologic test to diagnose pneumocystis pneumonia: are we there yet? Clin Infect Dis. 2011 Jul 15;53(2):203-4. No abstract available.
Gordin FM, Masur H. Current approaches to tuberculosis in the United States. JAMA. 2012 Jul 18;308(3):283-9.
Rasimas J, Katsounas A, Raza H, Murphy AA, Yang J, Lempicki RA, Osinusi A, Masur H, Polis M, Kottilil S, Rosenstein D. Gene expression profiles predict emergence of psychiatric adverse events in HIV/HCV-coinfected patients on interferon-based HCV therapy. J Acquir Immune Defic Syndr. 2012 Jul 1;60(3):273-81.